Literature DB >> 22093834

miR-125b suppresses the proliferation and migration of osteosarcoma cells through down-regulation of STAT3.

Li-hong Liu1, Hui Li, Jin-ping Li, Hui Zhong, Han-chon Zhang, Jia Chen, Tao Xiao.   

Abstract

There is accumulating evidence that microRNAs are involved in multiple processes in development and tumor progression. Abnormally expressed miR-125b was found to play a fundamental role in several types of cancer; however, whether miR-125b participates in regulating the initiation and progress of osteosarcoma still remains unclear. Here we demonstrate that miR-125b is frequently down-regulated in osteosarcoma samples and human osteosarcoma cell lines. The ectopic restoration of miR-125b expression in human osteosarcoma cells suppresses proliferation and migration in vitro and inhibits tumor formation in vivo. We further identified signal transducer and activator of transcription 3 (STAT3) as the direct and functional downstream target of miR-125b. Interestingly, we discovered that the expression of miR-125b is regulated by STAT3 at the level of transcription. STAT3 binds to the promoter region of miR-125b in vitro and serves as a transactivator. Taken together, our findings point to an important role in the molecular etiology of osteosarcoma and suggest that miR-125b is a potential target in the treatment of osteosarcoma.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22093834     DOI: 10.1016/j.bbrc.2011.10.117

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  81 in total

1.  MicroRNA screening identifies circulating microRNAs as potential biomarkers for osteosarcoma.

Authors:  Hui Li; Kun Zhang; Li-Hong Liu; Yurong Ouyang; Hong-Bin Guo; Hanchong Zhang; Jie Bu; Tao Xiao
Journal:  Oncol Lett       Date:  2015-06-16       Impact factor: 2.967

2.  microRNA-363 plays a tumor suppressive role in osteosarcoma by directly targeting MAP2K4.

Authors:  Xueqin Li; Xinsheng Liu; Jun Fang; Huazhuang Li; Jingchun Chen
Journal:  Int J Clin Exp Med       Date:  2015-11-15

3.  Regulation of onco and tumor suppressor MiRNAs by mTORC1 inhibitor PRP-1 in human chondrosarcoma.

Authors:  Karina A Galoian; Toumy Guettouche; Biju Issac; Amir Qureshi; H T Temple
Journal:  Tumour Biol       Date:  2013-11-01

4.  MicroRNAs and Glucocorticoid-Induced Apoptosis in Lymphoid Malignancies.

Authors:  Ronit Vogt Sionov
Journal:  ISRN Hematol       Date:  2013-01-29

Review 5.  miRNA signatures in childhood sarcomas and their clinical implications.

Authors:  G M Viera; K B Salomao; G R de Sousa; M Baroni; L E A Delsin; J A Pezuk; M S Brassesco
Journal:  Clin Transl Oncol       Date:  2019-04-04       Impact factor: 3.405

6.  Circulating miR-125b is a novel biomarker for screening non-small-cell lung cancer and predicts poor prognosis.

Authors:  Ma Yuxia; Tian Zhennan; Zhang Wei
Journal:  J Cancer Res Clin Oncol       Date:  2012-07-18       Impact factor: 4.553

7.  miR-125b-5p and miR-99a-5p downregulate human γδ T-cell activation and cytotoxicity.

Authors:  Yuli Zhu; Siya Zhang; Zinan Li; Huaishan Wang; Zhen Li; Yu Hu; Hui Chen; Xuan Zhang; Lianxian Cui; Jianmin Zhang; Wei He
Journal:  Cell Mol Immunol       Date:  2018-02-12       Impact factor: 11.530

8.  MicroRNA-125b regulates Th17/Treg cell differentiation and is associated with juvenile idiopathic arthritis.

Authors:  Zhi-Dan Fan; Qian Cao; Na Huang; Le Ma; Hui-Hui Ma; Ya-Yuan Zhang; Hai-Guo Yu; Guo-Ping Zhou
Journal:  World J Pediatr       Date:  2019-05-17       Impact factor: 2.764

9.  The microRNA miR-199a-5p down-regulation switches on wound angiogenesis by derepressing the v-ets erythroblastosis virus E26 oncogene homolog 1-matrix metalloproteinase-1 pathway.

Authors:  Yuk Cheung Chan; Sashwati Roy; Yue Huang; Savita Khanna; Chandan K Sen
Journal:  J Biol Chem       Date:  2012-10-11       Impact factor: 5.157

10.  miR-490-3p modulates cell growth and epithelial to mesenchymal transition of hepatocellular carcinoma cells by targeting endoplasmic reticulum-Golgi intermediate compartment protein 3 (ERGIC3).

Authors:  Ling-yun Zhang; Min Liu; Xin Li; Hua Tang
Journal:  J Biol Chem       Date:  2012-12-04       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.